---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-048139"
form_type: "8-K"
ticker: "GCTK"
cik: "0001506983"
company_name: "Glucotrack, Inc."
filed_at: "2026-10-22T21:29:23+00:00"
generated_at: "2026-10-22T21:30:13.070177+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Glucotrack raises $2M via 22% OID secured convertible notes and sets 1-for-2 reverse split

## Summary
- Issued $2.56M principal of 8% senior secured convertible notes due 9 months for $2.0M cash, a 22% original issue discount; default rate 18%.
- Notes convert at lower of $0.6390 or 80% of 15-day VWAP, floor 20% of Nasdaq Minimum Price; exchange cap 19.99% pending stockholder approval.
- Issued warrants for 8,025,360 shares at $1.5975, exercisable 5 years; Dawson James got 7% cash fee, 160,508 warrants at 125% of conversion price, up to $50K expenses.
- 1-for-2 reverse split effective Oct 26, 2026; outstanding shares fall from 2,368,237 to about 1,184,119; new CUSIP 45824Q879.
- Reverse split aims to regain Nasdaq $1.00 bid compliance by Nov 9, 2026, after prior 1-for-15 split on Aug 28, 2026; delisting possible if terms not met.

## SEC filing metadata
- accession: 0001493152-26-048139
- form_type: 8-K
- ticker: GCTK
- cik: 0001506983
- company_name: Glucotrack, Inc.
- filed_at: 2026-10-22T21:29:23+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506983/000149315226048139/0001493152-26-048139-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506983/000149315226048139/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-048139
- JSON: https://secwatch.observer/filing/0001493152-26-048139.json
- Plain text: https://secwatch.observer/filing/0001493152-26-048139.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.